PAPPA2 and preeclampsia: Similarly, a CpG site in the promoter region of Pregnancy-Associated Plasma Protein A2 (PAPPA2), whose expression is elevated in preeclampsia and is a promising biomarker for its detection [32], [33], [34], [35], exhibited reduced DNA methylation in preeclampsia samples compared to normal controls.